NCT02977052 2023-11-15
OpACIN-neo
The Netherlands Cancer Institute
Phase 2 Unknown
Clinical Trials
7 trialsNCT05906277 2023-06-15
Melamoma4p
Regina Elena Cancer Institute
Phase NA Unknown
NCT04136470 2020-08-10
BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics
Ardigen
Unknown
NCT02654821 2018-11-02
TCR
The Netherlands Cancer Institute
Phase 1/2 Unknown
NCT02625337 2017-09-15
IMPemBra
The Netherlands Cancer Institute
Phase 2 Unknown
NCT02938728 2016-10-25
PREDIMEL
Assistance Publique - Hôpitaux de Paris
Unknown
NCT00811759 2010-10-07
Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma
National Cancer Institute (NCI)
Phase 1/2 Unknown